Humedix Appoints 13 ‘AestheFill 2026 APAC Experts’

Humedix (CEO Kang Min-jong), the aesthetics affiliate of the Huons Group, announced on the 27th that it has recently appointed 13 academic advisors for ‘AestheFill’ as ‘AestheFill APAC Experts’ and presented them with certificates of appointment.

Humedix selected the APAC Experts from among Korean medical professionals who contributed to AestheFill’s academic activities in the first half of this year.

The appointed advisors are Kang Gun-woo (Newstar Clinic), Yoon Sung-eun and Lee Jung-wook (Brandnew Clinic), Lee Kyu-ho and Yoon Chang-il (U&I Clinic Mokdong), Lee Hyun-hee (Lewell Clinic), Park Shin-hye (Miho Clinic), Park Hee-sun (Monster Clinic), Choi Woong (VS Line Clinic), Park Seung-won (Ado Clinic), Lee Doochan (ReYeonK Clinic), Lee Bo-won (Dasibomnal Clinic Sinchon) and Mok Jung-hee (Nadri Clinic).

The certificates state that the recipients contributed to the academic advancement of Korean aesthetic medicine and to the clinical application of AestheFill, and convey gratitude for the expertise and experience they have shared. The appointed advisors have continued academic research into the clinical application of AestheFill through lectures, hands-on seminars and the sharing of clinical experience.

AestheFill is a poly-D,L-lactic acid (PDLLA) collagen stimulator. Its main components are PDLLA and carboxymethyl cellulose (CMC), and it is a Class 4 medical device approved for the temporary improvement of facial wrinkles. Humedix distributes it after securing exclusive domestic sales rights from Regen Biotech.

Taking this appointment as a starting point, Humedix plans to expand in stages an academic exchange programme centred on the AestheFill APAC Experts. Beyond domestic academic activity, it is reviewing the sharing of clinical experience with medical professionals across the Asia-Pacific region and programmes linked to international conferences.

Humedix CEO Kang Min-jong said, “AestheFill is a product that has developed together with more than ten years of accumulated clinical experience,” adding, “The APAC Expert appointment expresses our gratitude to the doctors who have led the academic discussion so far, and at the same time reflects our commitment to widening the academic network across the Asia-Pacific region.”